Catholic Health Services (CHS), an integrated health care delivery system with a 24% market share on Long Island, is teaming up with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to enhance the quality and value of diagnostic services to patients and their doctors
Postnova Analytics reports on a new method for the accurate molecular weight determination of complex polysaccharides (Chitosans) using asymmetric flow field flow fractionation (AF4) coupled with multi-angle light scattering (MALS) and differential refractive index (RI) detectors
The Parkinson's Foundation is pleased to announce the launch of PD GENEration: Mapping the Future of Parkinson's Disease, a first-of-its-kind national initiative that offers free genetic testing for clinically relevant Parkinson's-related genes and free genetic counseling to help participants better understand their results
EKF Diagnostics, the global in vitro diagnostics company, announces that its Quo-Test HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening diabetic retinopathy (STDR)
SpeeDx Pty. Ltd. recently announced ResistancePlus MG has been cleared by Health Canada and is now available for sale across all Canadian provinces (not currently available in the U.S.)
Working closely with a medical device manufacturer, Porvair Sciences has developed a high-performance fluid collection vent for a surgical suction cannister using their proprietary Vyon porous plastic
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin
Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced today that it was selected by MedTech Outlook to receive the 2019 Top 10 In-Vitro Diagnostics Award
Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new solution will bring the latest screening technology to U.S. blood and plasma centers
The DrySyn ChilliBlock from Asynt allows you to undertake sensitive biological assays in a temperature-controlled manor, vastly reducing the risk of expensive biological samples, reagents or enzymes degrading due to adverse temperature conditions
|
|
|
|
|
|
|
|
|